Antioxidant use in IDH1 mutant tumors - Hallo friendsTOP POLENNEWS, In the article you read this time with the title Antioxidant use in IDH1 mutant tumors, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article cultur, Article economic, Article health, Article news, Article politique, Article sport, We write this you can understand. Alright, good read.

Title : Antioxidant use in IDH1 mutant tumors
link : Antioxidant use in IDH1 mutant tumors

Antioxidant use in IDH1 mutant tumors

I'd like to open a topic up for debate here regarding antioxidant use in IDH1 mutant tumors. My understanding is that IDH1 mutant tumors are characterized by generally low Glutathione (antioxidant) levels, significantly sensitizing them to ROS generation. Some researchers speculate that this is the primary reason for superior OS stats for IDH1 mutant tumors, e.g.:

https://www.ncbi.nlm.nih.gov/pubmed/24362902

Given this particular dynamic, should I conclude that use of antioxidants which stimulate Glutathione (e.g. Alpha Lipoic Acid, Green tea, Cinnamon,...) should better be avoided in the case of IDH1 mutant tumors?

I am particularly interested in this question as my tumor is IDH1 mutated, and I recently started taking the Metabloc protocol (Alpha Lipoic Acid + Hydroxycitrate), since it seems to deliver very promising synergy with Metformin use. After investigating a bit, I am contemplating skipping the Alpha Lipoic Acid, however. 

Any thoughts on this topic? Thanks!

John

Thus Article Antioxidant use in IDH1 mutant tumors

That's an article Antioxidant use in IDH1 mutant tumors This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article Antioxidant use in IDH1 mutant tumors with the link address https://polennews.blogspot.com/2019/07/antioxidant-use-in-idh1-mutant-tumors.html

Tweet

Subscribe to receive free email updates: